A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Clinical trial NCT07538804 · RECRUITING
Trial details
- NCT number
- NCT07538804
- Sponsor
- Avistone Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-10
- Primary completion
- 2029-06-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.